Found: 20
Select item for more details and to access through your institution.
Intestinal Tissue Levels of Anti-Tumour Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases: Are We Looking in The Right Place at The Right Time?
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 869, doi. 10.1093/ecco-jcc/jjab233
- By:
- Publication type:
- Article
Impact of Anti-tumour Necrosis Factor Alpha Agents on the Risk of Colorectal Cancer.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 871, doi. 10.1093/ecco-jcc/jjab198
- By:
- Publication type:
- Article
Prognostic Biosignatures at Ileocecal Resection: Hope or Reality?
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 873, doi. 10.1093/ecco-jcc/jjab203
- By:
- Publication type:
- Article
ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 876, doi. 10.1093/ecco-jcc/jjac006
- By:
- Publication type:
- Article
Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 884, doi. 10.1093/ecco-jcc/jjab208
- By:
- Publication type:
- Article
Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 893, doi. 10.1093/ecco-jcc/jjab184
- By:
- Publication type:
- Article
Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease Recurrence.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 900, doi. 10.1093/ecco-jcc/jjab186
- By:
- Publication type:
- Article
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS].
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 911, doi. 10.1093/ecco-jcc/jjab224
- By:
- Publication type:
- Article
Efficacy of Pharmacological Agents for Ulcerative Proctitis: A Systematic Literature Review.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 922, doi. 10.1093/ecco-jcc/jjab218
- By:
- Publication type:
- Article
Western and Carnivorous Dietary Patterns are Associated with Greater Likelihood of IBD Development in a Large Prospective Population-based Cohort.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 931, doi. 10.1093/ecco-jcc/jjab219
- By:
- Publication type:
- Article
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 940, doi. 10.1093/ecco-jcc/jjab217
- By:
- Publication type:
- Article
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 946, doi. 10.1093/ecco-jcc/jjab213
- By:
- Publication type:
- Article
Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 954, doi. 10.1093/ecco-jcc/jjab215
- By:
- Publication type:
- Article
Gut Epithelial-derived CXCL9 Maintains Gut Homeostasis Through Preventing Overgrown E. coli.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 963, doi. 10.1093/ecco-jcc/jjab234
- By:
- Publication type:
- Article
Selective Targeting of Tumour Necrosis Factor Receptor 1 Induces Stable Protection from Crohn's-Like Ileitis in TNFΔARE Mice.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 978, doi. 10.1093/ecco-jcc/jjab222
- By:
- Publication type:
- Article
MicroRNA and Gut Microbiota: Tiny but Mighty—Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 992, doi. 10.1093/ecco-jcc/jjab223
- By:
- Publication type:
- Article
Launch of an Online National Multidisciplinary Expert Panel for Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 1006, doi. 10.1093/ecco-jcc/jjac002
- By:
- Publication type:
- Article
Corrigendum to: Mincle/Syk Signalling Promotes Intestinal Mucosal Inflammation Through Induction of Macrophage Pyroptosis in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 1008, doi. 10.1093/ecco-jcc/jjab193
- By:
- Publication type:
- Article
Corrigendum to: Long-term Oncological Outcome of Segmental Versus Extended Colectomy for Colorectal Cancer in Crohn's Disease: Results from an International Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 1009, doi. 10.1093/ecco-jcc/jjac022
- By:
- Publication type:
- Article
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 1010, doi. 10.1093/ecco-jcc/jjab107
- By:
- Publication type:
- Article